Switch to:
More From Other Websites
This stock may be hazardous to your financial health Aug 19 2014
U.S. FDA approves Sanofi's Gaucher disease drug Cerdelga Aug 19 2014
Pfizer Submits Palbociclib Marketing Application to the FDA Aug 19 2014
The Negative Impact Of Pfizer's Mergers And Budget Cuts On Cancer R&D Aug 19 2014
U.S. clears AstraZeneca over heart drug trial Aug 19 2014
Pfizer Announces Submission of Palbociclib New Drug Application to the FDA Aug 18 2014
Washington Post Off Base In Critiquing Pharma Efforts In Ebola Aug 18 2014
Pfizer Announces Submission of Palbociclib New Drug Application to the FDA Aug 18 2014
Premier Biotechnology & Anti-CTLA4 Aug 18 2014
8:00 am Pfizer announces submission of Palbociclib NDA to the FDA Aug 18 2014
Pfizer is Liable for Harm Caused by a Generic Version of its Drug: Court Aug 15 2014
PFIZER INC Financials Aug 15 2014
Digital Transformation Moves Pharma 'Beyond the Pill' Aug 15 2014
Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application... Aug 14 2014
Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application... Aug 14 2014
Pfizer's Prevnar 13 Backed by U.S. Panel for Expanded Use Aug 14 2014
[video] Pfizer and Merck Receive Key Regulatory Approvals Aug 14 2014
[video] Howard Hughes, Pfizer Will Head Higher Says Becker Fund Manager Aug 14 2014
U.S. judge lets investors pursue SAC insider trading lawsuit Aug 14 2014
Why Pfizer (PFE) Stock Is Up Today Aug 14 2014


Add Notes, Comments or Ask Questions

User Comments

SEENSCO
ReplySEENSCO - 2 months ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide